These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3100517)

  • 1. Tissue factor (coagulation factor III) inhibition by apolipoprotein A-II.
    Carson SD
    J Biol Chem; 1987 Jan; 262(2):718-21. PubMed ID: 3100517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that plasma lipoproteins inhibit the factor VIIa-tissue factor complex by a different mechanism that extrinsic pathway inhibitor.
    Kondo S; Kisiel W
    Blood; 1987 Dec; 70(6):1947-54. PubMed ID: 3315045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of lipid-binding proteins apo A-I, apo A-IL, beta 2-glycoprotein I, and C-reactive protein on activation of factor X by tissue factor--factor VIIa.
    Carson SD; Ross SE
    Thromb Res; 1988 Jun; 50(5):669-78. PubMed ID: 3137684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human extrinsic pathway inhibitor. Production, isolation, and characterization of its inhibitory activity on tissue factor-initiated coagulation reactions.
    Pedersen AH; Nordfang O; Norris F; Wiberg FC; Christensen PM; Moeller KB; Meidahl-Pedersen J; Beck TC; Norris K; Hedner U
    J Biol Chem; 1990 Oct; 265(28):16786-93. PubMed ID: 2211593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An ordered addition, essential activation model of the tissue factor pathway of coagulation: evidence for a conformational cage.
    Nemerson Y; Gentry R
    Biochemistry; 1986 Jul; 25(14):4020-33. PubMed ID: 3091068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue factor-dependent autoactivation of human blood coagulation factor VII.
    Yamamoto M; Nakagaki T; Kisiel W
    J Biol Chem; 1992 Sep; 267(27):19089-94. PubMed ID: 1527033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma high density lipoproteins inhibit the activation of coagulation factor X by factor VIIa and tissue factor.
    Carson SD
    FEBS Lett; 1981 Sep; 132(1):37-40. PubMed ID: 6795061
    [No Abstract]   [Full Text] [Related]  

  • 8. The contributions of Ca2+, phospholipids and tissue-factor apoprotein to the activation of human blood-coagulation factor X by activated factor VII.
    Bom VJ; Bertina RM
    Biochem J; 1990 Jan; 265(2):327-36. PubMed ID: 2302175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of the inhibition of factor Xa and the tissue factor-factor VIIa complex by the tissue factor pathway inhibitor in the presence and absence of heparin.
    Jesty J; Wun TC; Lorenz A
    Biochemistry; 1994 Oct; 33(42):12686-94. PubMed ID: 7918495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, antithrombin-III, and heparin cofactor-II.
    van 't Veer C; Mann KG
    J Biol Chem; 1997 Feb; 272(7):4367-77. PubMed ID: 9020158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phospholipid regulates the activation of factor X by tissue factor/factor VIIa (TF/VIIa) via substrate and product interactions.
    Hathcock JJ; Rusinova E; Gentry RD; Andree H; Nemerson Y
    Biochemistry; 2005 Jun; 44(22):8187-97. PubMed ID: 15924438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane-dependent coagulation reaction is independent of the concentration of phospholipid-bound substrate: fluid phase factor X regulates the extrinsic system.
    Forman SD; Nemerson Y
    Proc Natl Acad Sci U S A; 1986 Jul; 83(13):4675-9. PubMed ID: 3487782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phospholipid surfaces regulate the delivery of substrate to tissue factor:VIIa and the removal of product.
    Hathcock JJ; Rusinova E; Andree H; Nemerson Y
    Blood Cells Mol Dis; 2006; 36(2):194-8. PubMed ID: 16529959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initiation of the extrinsic pathway of coagulation. Association of factor VIIa with a cell line expressing tissue factor.
    Ploplis VA; Edgington TS; Fair DS
    J Biol Chem; 1987 Jul; 262(20):9503-8. PubMed ID: 3496335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of a mechanism inhibiting the initiation of the extrinsic pathway of coagulation.
    Rao LV; Rapaport SI
    Blood; 1987 Feb; 69(2):645-51. PubMed ID: 3492226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperative interaction between factor VII and cell surface-expressed tissue factor.
    Fair DS; MacDonald MJ
    J Biol Chem; 1987 Aug; 262(24):11692-8. PubMed ID: 3624232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of human factor VII activation.
    Butenas S; Mann KG
    Biochemistry; 1996 Feb; 35(6):1904-10. PubMed ID: 8639673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional properties of factor VIIa/tissue factor formed with purified tissue factor and with tissue factor expressed on cultured endothelial cells.
    Almus FE; Rao LV; Rapaport SI
    Thromb Haemost; 1989 Dec; 62(4):1067-73. PubMed ID: 2617454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The regulation of the factor VII-dependent coagulation pathway: rationale for the effectiveness of recombinant factor VIIa in refractory bleeding disorders.
    van't Veer C; Mann KG
    Semin Thromb Hemost; 2000; 26(4):367-72. PubMed ID: 11092210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of binding of recombinant extrinsic pathway inhibitor (rEPI) to cultured cell surfaces. Evidence that rEPI can bind to and inhibit factor VIIa-tissue factor complexes in the absence of factor Xa.
    Callander NS; Rao LV; Nordfang O; Sandset PM; Warn-Cramer B; Rapaport SI
    J Biol Chem; 1992 Jan; 267(2):876-82. PubMed ID: 1730676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.